Compass Therapeutics Stock Price Prediction
| CMPX Stock | USD 1.70 0.05 3.03% |
Oversold Vs Overbought
33
Oversold | Overbought |
Compass Therapeutics stock price prediction is an act of determining the future value of Compass Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Compass Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Compass Therapeutics and does not consider all of the tangible or intangible factors available from Compass Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Compass Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Compass Therapeutics' stock price prediction:EPS Estimate Next Quarter (0.10) | EPS Estimate Current Year (0.48) | EPS Estimate Next Year (0.50) | Wall Street Target Price 9.17 | EPS Estimate Current Quarter (0.09) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Compass Therapeutics based on different types of headlines from major news networks to social media. The Compass stock price prediction module provides an analysis of price elasticity to changes in media outlook on Compass Therapeutics over a specific investment horizon. Using Compass Therapeutics hype-based prediction, you can estimate the value of Compass Therapeutics from the perspective of Compass Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Compass Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Compass Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Compass because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Compass Therapeutics after-hype prediction price | USD 1.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Compass |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Compass Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Compass Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Compass Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Compass Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Compass Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Compass Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Compass Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Compass Therapeutics' historical news coverage. Compass Therapeutics' after-hype downside and upside margins for the prediction period are 0.08 and 7.16, respectively. We have considered Compass Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Compass Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Compass Therapeutics is based on 3 months time horizon.
Compass Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Compass Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Compass Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Compass Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.70 | 5.56 | 0.10 | 0.24 | 9 Events / Month | 16 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.70 | 1.60 | 5.88 |
|
Compass Therapeutics Hype Timeline
Compass Therapeutics is currently traded for 1.70. The entity has historical hype elasticity of -0.1, and average elasticity to hype of competition of -0.24. Compass is projected to decline in value after the next headline, with the price expected to drop to 1.6. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -5.88%, whereas the daily expected return is currently at 0.7%. The volatility of related hype on Compass Therapeutics is about 1628.76%, with the expected price after the next announcement by competition of 1.46. About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.5. Some equities with similar Price to Book (P/B) outperform the market in the long run. Compass Therapeutics recorded a loss per share of 0.33. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Compass Therapeutics Basic Forecasting Models to cross-verify your projections.Compass Therapeutics Related Hype Analysis
Having access to credible news sources related to Compass Therapeutics' direct competition is more important than ever and may enhance your ability to predict Compass Therapeutics' future price movements. Getting to know how Compass Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Compass Therapeutics may potentially react to the hype associated with one of its peers.
Compass Therapeutics Additional Predictive Modules
Most predictive techniques to examine Compass price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Compass using various technical indicators. When you analyze Compass charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Compass Therapeutics Predictive Indicators
The successful prediction of Compass Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Compass Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Compass Therapeutics based on analysis of Compass Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Compass Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Compass Therapeutics's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 13.84 | 12.05 | 10.84 | 6.48 | Net Debt To EBITDA | 4.74 | 0.86 | 0.77 | 1.38 |
Story Coverage note for Compass Therapeutics
The number of cover stories for Compass Therapeutics depends on current market conditions and Compass Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Compass Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Compass Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Compass Therapeutics Short Properties
Compass Therapeutics' future price predictability will typically decrease when Compass Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Compass Therapeutics often depends not only on the future outlook of the potential Compass Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Compass Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 127.7 M |
Check out Compass Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Compass Stock analysis
When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Compass Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compass Therapeutics. If investors know Compass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compass Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.33) | Return On Assets (0.18) | Return On Equity (0.26) |
The market value of Compass Therapeutics is measured differently than its book value, which is the value of Compass that is recorded on the company's balance sheet. Investors also form their own opinion of Compass Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Compass Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compass Therapeutics' market value can be influenced by many factors that don't directly affect Compass Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compass Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Compass Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compass Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.